INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/19/2025
Back to search
Official data from USPTO
SEQUESSOME TECHNOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEQUESSOME TECHNOLOGY
ST13
US500000079115050Class
5, 10
Filing
79115050
Registration
4427020
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/14/2025
Trademark type
Word
Nice classes
5, 10
Filing date
12/20/2011
Registration date
11/05/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/17/2024
Last transaction
05/14/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Berkshire, GB
Examiner
TWOHIG,SHANNON MARIE
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pro Bono Bio Entrepreneur Limited
Pro Bono Bio Entrepreneur Limited
Representatives
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of pain and inflammation; veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposesfor the treatment of pain and inflammation; pharmaceuticals for the treatment of osteoarthritisoncologycardiovascular diseaserespiratory diseaseinflammationinfectiongastrointestinal diseases and central nervous system diseases; diagnostic preparations for medical and veterinary use; anti-inflammatory drugs; medicated creamsmedicated dispersionsmedicated lotionsmedicated ointmentsmedicated gelsmedicated solutionsmedicated spraysmedicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain or inflammation; chemical preparations for pharmaceutical or medical purposesthe treatment of pain and inflammation; pharmaceuticals in the fields of osteoarthritisoncologycardiovascular diseaserespiratory diseaseinflammationinfectiongastrointestinal disease and central nervous system diseasesvesicles which physically absorb and remove chemicals; pharmaceutical preparationstopical and parenteral preparations in the form of vesicles; pharmaceutical preparations in the form of vesicles for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes for the treatment of pain and inflammation; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammation; dispersions for pharmaceuticals for the treatment of pain and inflammation; medicated cosmetic and veterinary preparationsdispersions and dry preparations of liposomal active substance carriers for the treatment of pain and inflammation; cosmeceutical preparations in the nature of medicated cosmetics; pharmaceutical preparationslipids for topical and parenteral use for the treatment of pain and inflammation; surfactants for medical use dispersed in the form of liquidscreamsgelslotionsliquid treatment sprays and lotionsbeing pharmaceutical preparations for the treatment of or prevention of cancerinfectious diseasesfungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of mouthteethskinhair and earbone and blood diseases and reproductive system disordersthe treatment of inflammationasthmaatopic eczemadishydrotic hand eczemaplaque-type psoriasisseborrhoeic eczemaacne vulgarisbronchospasmatherothrombotic cardiovascular disordersvenous thrombotic disorderspaindysmenorrheahypercholesterolemiahypertriglyceridemiafatty acid metabolismmetal or other toxicityAlzheimer's diseasegoutmacular degenerationfungal disease and disorders related to fatty acid deficiencies
Class 10
Medical devices in the nature of a carrier with nanostructures which cross through the skin allowing subcutaneous absorption for the treatment of pain; molecular filtering devices for medical usea liquidgel or cream preparation as a drug delivery device which filters through or migrates into the skin and has a physical therapeutic effect; medical and veterinary devicesa medical device in which vesicles act as a drug delivery device in the nature of non-pharmaceutical nanostructures that migrate through the skin and which contribute to the lubricating properties of synovial fluid ; medical instruments and devices for the administration of skin disease therapy and pain therapy and prophylaxis preparations and substances
Publications
History of USPTO decisions and trademark events.
48 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/01/2025
INPC
INVALIDATION PROCESSED
04/01/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/18/2025
C71T
CANCELLED SECTION 71
05/17/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/05/2022
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/07/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/07/2020
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01/07/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2019
ES75
TEAS SECTION 71 & 15 RECEIVED
11/05/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/09/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/05/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/14/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/14/2016
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2014
FIMP
FINAL DISPOSITION PROCESSED
02/07/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2013
PUBO
PUBLISHED FOR OPPOSITION
08/20/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/17/2013
ALIE
ASSIGNED TO LIE
07/17/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/15/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/08/2013
GNFR
FINAL REFUSAL E-MAILED
03/08/2013
CNFR
FINAL REFUSAL WRITTEN
03/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/14/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2013
ALIE
ASSIGNED TO LIE
02/12/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2013
RFNT
REFUSAL PROCESSED BY IB
09/01/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2012
RFRR
REFUSAL PROCESSED BY MPU
08/10/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/10/2012
CNRT
NON-FINAL ACTION WRITTEN
08/09/2012
MAFR
APPLICATION FILING RECEIPT MAILED
08/07/2012
DOCK
ASSIGNED TO EXAMINER
08/03/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/02/2012
Continuous trademark protection
Get notified about every new filing that threatens SEQUESSOME TECHNOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.